Combination treatment with ibrilatazar and chemotherapy has demonstrated “promising efficacy and safety” in patients with advanced squamous non-small cell lung cancer (NSCLC), according to researchers ...

NSAID use is associated with an increased risk of death from RCC among women but not among men, researchers found.

New research suggests that, from 2011 to 2023, there was an increase in early adult mortality in the United States.

New research suggests that cancer survivors experiencing pain are more likely to use cannabis and cigarettes but less likely to consume alcohol than cancer survivors without pain.

Being obese at the time of MGUS diagnosis was associated with a 27% increase in the risk of progression to MM.

The FDA has granted fast track designation to amezalpat for the treatment of patients with hepatocellular carcinoma.

Artificial intelligence systems require consistent monitoring and staffing to put in place and to keep them working well.

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

The NIH said this change will save billions of dollars. Universities said it will disrupt vital, life-saving research.

Patients with stage IA HER2+ breast cancer and smaller tumors had high BCSS rates whether they received adjuvant chemotherapy or not.

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

The Trump Administration’s censorship extends beyond federal websites and datasets to include research to be published in academic journals.